Increased expression of endothelin-converting enzyme-1c isoform in response to high glucose levels in endothelial cells

Journal of Vascular Research

Volumn 41, Issue 2, 2004, Pages 131-140

  Keynan, Shoshana ^a   Khamaisi, Mogher ^a   Dahan, Rachel ^a   Barnes, Kay ^b   Jackson, Carolyn D ^b   Turner, Anthony J ^b   Raz, Itamar ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

Endothelin 1; Endothelin converting enzyme; Nitric oxide; Protein kinase C

Indexed keywords

2 [1 (3 DIMETHYLAMINOPROPYL) 3 INDOLYL] 3 (3 INDOLYL)MALEIMIDE; BRADYKININ; ENDOTHELIN CONVERTING ENZYME; ENDOTHELIN CONVERTING ENZYME 1A; ENDOTHELIN CONVERTING ENZYME 1B; ENDOTHELIN CONVERTING ENZYME 1C; ENDOTHELIN CONVERTING ENZYME 1D; GLUCOSE; ISOENZYME; MESSENGER RNA; N(G) NITROARGININE METHYL ESTER; PHORBOL MYRISTATE; PROTEIN KINASE C; PROTEIN KINASE C INHIBITOR; UNCLASSIFIED DRUG;

ARTICLE; CELL GROWTH; CELL MEMBRANE; CONCENTRATION (PARAMETERS); ENDOTHELIUM CELL; ENZYME ACTIVITY; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN CELL; HYBRID CELL; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION; UMBILICAL VEIN; VASCULAR ENDOTHELIUM;

ASPARTIC ENDOPEPTIDASES; CELLS, CULTURED; DIABETIC NEPHROPATHIES; ENDOTHELIUM, VASCULAR; EPITHELIAL CELLS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GLUCOSE; HUMANS; ISOENZYMES; LUNG; METALLOENDOPEPTIDASES; NITRIC OXIDE; PROTEIN KINASE C; RNA, MESSENGER; UMBILICAL VEINS;

EID: 1842628557     PISSN: 10181172     EISSN: None     Source Type: Journal    
DOI: 10.1159/000077132     Document Type: Article

References (50)

1. Di Mario U, Pugliese G: 15th Golgi lecture: From hyperglycaemia to the dysregulation of vascular remodelling in diabetes. Diabetologia 2001;44:674-692.
2. Luscher TF, Barton M: Biology of the endothelium. Clin Cardiol 1997;20:II3-II10.
3. Hopfner RL, Gopalakrishnan V: Endothelin: Emerging role in diabetic vascular complications. Diabetologia 1999;42:1383-1394.
4. Park JY, Takahara N, Gabriele A, Chou E, Naruse K, Suzuma K, Yamauchi T, Ha SW, Meier M, Rhodes CJ, King GL: Induction of endothelin-1 expression by glucose: An effect of protein kinase C activation. Diabetes 2000;49:1239-1248.
5. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K, Masaki T: A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988;332:411-415.
6. Inoue A, Yanagisawa M, Kimura S, Kasuya Y, Miyauchi T, Goto K, Masaki T: The human endothelin family: Three structurally and pharmacologically distinct isopeptides predicted by three separate genes. Proc Natl Acad Sci USA 1989;86:2863-2867.
7. Battistini B, Chailler P, D'Orleans-Juste P, Brière N, Sirois P: Growth regulatory properties of endothelins. Peptides 1993;14:385-399.
8. Arai H, Hori S, Aramori I, Ohkubo H, Nakanishi S: Cloning and expression of a cDNA encoding an endothelin receptor. Nature 1990;348;730-732.
9. Sakurai T, Yanagisawa M, Takuwa Y, Miyazaki H, Kimura S, Goto K, Masaki T: Cloning of a cDNA encoding a non-isopeptide selective subtype of the endothelin receptor. Nature 1990;348:732-735.
10. De Nucci G, Thomas R, D'Orleans-Juste P, Antunes E, Walder C, Warner TD, Vane JR: Pressor effects of circulating endothelin are limited by its removal from the pulmonary circulation and by the release of prostacyclin and endothelium-derived relaxing factor. Proc Natl Acad Sci USA 1988;85:9797-9800.
11. Takahashi M, Matsushita Y, Iijima Y, Tanzawa K: Purification and characterization of endothelin converting enzyme from rat lung. J Biol Chem 1993;268:21394-21398.
12. Ikura T, Sawamura T, Shiraki T, Hosokawa H, Kido T, Hoshikawa H, Shimada K, Tanzawa K, Kobayashi S, Miwa S, Masaki T: cDNA cloning and expression of bovine endothelin converting enzyme. Biochem Biophys Res Commun 1994;203:1417-1422.
13. Schmidt M, Kroger B, Jacob E, Seulberger H, Subkowski T, Otter R, Meyer T, Schmalzing G, Hillen H: Molecular characterization of human and bovine endothelin converting enzyme (ECE-1). FEBS Lett 1994;356:238-243.
14. Shimada K, Takahashi M, Tanzawa K: Cloning and functional expression of the endothelin-converting enzyme from rat endothelial cells. J Biol Chem 1994;269:18275-12278.
15. Shimada K, Takahashi M, Ikeda M, Tanzawa K: Identification and characterization of two isoforms of an endothelin converting enzyme-1. FEBS Lett 1995;371:140-144.
16. Xu D, Emoto N, Giaid A, Slaughter C, Kaw S, deWit D, Yanagisawa M: ECE-1:A membrane-bound metalloprotease that catalyses the proteolytic activation of big endothelin-1. Cell 1994;78:473-485.
17. Emoto N, Yanagisawa M: Endothelin-converting enzyme-2 is a membrane-bound, phosphoramidon-sensitive metalloprotease with acidic pH optimum. J Biol Chem 1995;270:15262-15268.
18. Ikegawa R, Matsumura Y, Tsukahara Y, Takaoka M, Morimoto S: Phosphoramidon, a metalloproteinase inhibitor suppresses the secretion of endothelin-1 from cultured endothelial cells by inhibiting a big endothelin-1 converting enzyme. Biochem Biophys Res Commun 1990;171:669-675.
19. Sawamura T, Kasuya Y, Matsushita Y, Suzuki N, Shinmi O, Kishi N, Sugita Y, Yanagisawa M, Goto K, Masaki T: Phosphoramidon inhibits the intracellular conversion of big endothelin-1 to endothelin-1 in cultured endothelial cells. Biochem Biophys Res Commun 1991; 174:779-784.
20. Matsumura Y, Hisaki K, Takaoka M, Morimoto S: Phosphoramidon, a metalloproteinase inhibitor suppresses the hypertensive effect of big endothelin-1. Eur J Pharmacol 1990;185:103-106.
21. McMahon EG, Palomo MA, Moore WM, McDonald JF, Stern MK: Phosphoramidon blocks the pressor activity of porcine big endothelin-1 (1-39) in vivo and conversion of big endothelin-1 (1-39) to endothelin-1 (1-21) in vitro. Proc Natl Acad Sci USA 1991;88:703-707.
22. Corder R, Vane JR: Radioimmunoassay evidence that the pressor effect of big endothelin-1 is due to local conversion to endothelin-1. Biochem Pharmacol 1995;49:375-380.
23. Schweizer A, Valdenaire O, Nelböck P, Deuschle U, Dumas M, Edwards JB, Stumpf JG, Löffler BM: Human endothelin converting enzyme (ECE-1): Three isoforms with distinct subcellular localizations. Biochem J 1997;328:871-877.
24. Valdenaire O, Lepailleur-Enouf D, Edidy G, Thouard A, Barrer A, Vranckx R, Tougard C, Michel JB: A fourth isoform of endothelin-converting enzyme (ECE-1) is generated from an additional promoter. Eur J Biochem 1999;264:341-349.
25. Shimada K, Matsushita Y, Wakabayashi K, Takahashi M, Matsubara A, Iijima Y, Tanzawa K: Cloning and functional expression of human endothelin-converting enzyme cDNA. Biochem Biophys Res Commun 1995;207:807-812.
26. Takahashi M, Fukuda K, Shimada K, Barnes K, Turner AJ, Ikeda M, Koike H, Yamamoto Y, Tanzawa K: Localization of rat endothelin converting enzyme to vascular endothelial cells and some secretory cells. Biochem J 1995;311:657-665.
27. Barnes K, Shimada K, Takahashi M, Tanzawa K, Turner AJ: Metallopeptidase inhibitors induce an up-regulation of endothelin-converting enzyme levels and its redistribution from plasma membrane to an intracellular compartment. J Cell Sci 1996;109:919-928.
28. Brown CD, Barnes K, Turner AJ: Anti-peptide antibodies specific to rat endothelin-converting enzyme-1 isoforms reveal isoform localization and expression. FEBS Lett 1998;424:183-187.
29. Edgell CJS, McDonald CC, Graham JB: Permanent cell line expressing human factor VIII-related antigen established by hybridization. Proc Natl Acad Sci USA 1983;80:3734-3737.
30. Waxman L, Doshi KP, Gaul SL, Wang S, Bednar RA, Stern AM: Identification and characterization of endothelin converting activity from EA.hy 926 cells: Evidance for the physiologically relevant human enzyme. Arch Biochem Biophys 1994;308:240-253.
31. Inoue A, Yanagisawa M, Takuwa Y, Mitsui Y, Kobayashi M, Masaki T: The human preproendothelin-1 gene: Complete nucleotide sequence and regulation of expression. J Biol Chem 1989;264:14954-14959.
32. Braiman L, Sheffi-Friedman L, Bak A, Tennenbaum T, Sampson SR: Tyrosine phosphorylation of specific protein kinase C isoenzymes participates in insulin stimulation of glucose transport in primary cultures of rat skeletal muscle. Diabetes 1999;48:1922-1929.
33. Takahashi K, Ghatei MA, Lam HC, O'Halloran DJ, Bloom SR: Elevated plasma endothelin in patients with diabetes mellitus. Diabetologia 1990;33:306-310.
34. Makino A, Kamata K: Time-course changes in plasma endothelin-1 and its effects on the mesenteric arterial bed in streptozotocin-induced diabetic rats. Diabetes Obes Metab 2000;2:47-55.
35. Hopfner RL, Hasnadka RV, Wilson TW, McNeill JR, Gopalakrishnan V: Insulin increases endothelin-1 evoked intracellular free calcium responses by increased ET(A) receptor expression in aortic smooth muscle cells. Diabetes 1998;47:937-944.
36. Turner AJ, Barnes K, Schweizer A, Valdenaire O: Isoforms of endothelin-converting enzyme: Why and where? Trends Pharmcol Sci 1998;19:483-486.
37. Cosentino F, Hishikawa K, Katusic ZS, Luscher TF: High glucose increases nitric oxide synthase expression and superoxide anion generation in human aortic endothelial cells. Circulation 1997;96:25-28.
38. Banting JD, Friberg P, Adams MA: Acute hypertension after nitric oxide synthase inhibition is mediated primarily by increased endothelin vasoconstriction. J Hypertens 1996;14:975-981.
39. Hinson JP, Kapas S, Cameron LA: Differential effects of endogenous and exogenous nitric oxide on the release of endothelin-1 from intact perfused rat adrenal gland in situ. FEBS Lett 1996;379:7-10.
40. Lee TS, Saltsman KA, Ohashi H, King GL: Activation of protein kinase C by elevation of glucose concentration: Proposal for mechanism in the development of diabetic vascular complications. Proc Natl Acad Sci USA 1989;86:5141-5145.
41. Pieper GM, Riaz-ul-Haq: Activation of nuclear factor-kappaB in cultured endothelial cells by increased glucose concentration: Prevention by calphostin C. J Cardiovasc Pharmacol 1997;30:528-532.
42. Liu W, Schoenkerman A, Lowe WL Jr: Activation of members of the mitogen-activated protein kinase family by glucose in endothelial cells. Am J Physiol Endocrinol Metab 2000;279:E782-E790.
43. Koya D, King GL: Protein kinase C activation and development of diabetic complications. Diabetes 1998;47:859-866.
44. Idris I, Gray S, Donnelly R: Protein kinase C activation: Isoenzyme-specific effects on metabolism and cardiovascular complications in diabetes. Diabetologia 2001;44:659-673.
45. Orzechowski HD, Richter CM, Funke-Kaiser H, Kroger B, Schmidt M, Menzel S, Bohnemeier H, Paul M: Evidence of alternative promoters directing isoform-specific expression of human endothelin-converting enzyme-1 mRNA in cultured endothelial cells. J Mol Med 1997;75:512-521.
46. Dorfman DM, Wilson DB, Burns GA, Orkin SH: Human transcription factor GATA-2. Evidence for regulation of preproendothelin-1 gene expression in endothelial cells. J Biol Chem 1992;267:1279-1285.
47. Zhang R, Min W, Sessa WC: Functional analysis of the human endothelial nitric oxide synthase promoter. Sp1 and GATA factors are necessary for basal transcription in endothelial cells. J Biol Chem 1995;270:15320-15326.
48. Khachigian LM, Williams AJ, Collins T: Interplay of Sp1 and Egr-1 in the proximal platelet-derived growth factor A-chain promoter in cultured vascular endothelial cells. J Biol Chem 1995;270:27679-27686.
49. Resnick N, Gimbrone MA Jr: Hemodynamic forces are complex regulators of endothelial gene expression. FASEB J 1995;9:874-882.
50. Valdenaire O, Rohrbacher E, Mattei MG: Organization of the gene encoding the human endothelin converting enzyme (ECE-1). J Biol Chem 1995;270:29794- 29798.